Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

  • Rea Federico1Email author,
  • Favaretto Adolfo2,
  • Marulli Giuseppe1,
  • Spaggiari Lorenzo3,
  • DePas Tommaso Martino4,
  • Ceribelli Anna5,
  • Paccagnella Adriano6,
  • Crivellari Gino6,
  • Russo Francesca7,
  • Ceccarelli Matteo7,
  • Kazeem Gbenga8,
  • Marchi Paolo7Email author and
  • Facciolo Francesco9
BMC Cancer201313:22

DOI: 10.1186/1471-2407-13-22

Received: 3 April 2012

Accepted: 4 January 2013

Published: 16 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
3 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Apr 2012 Author responded Author comments - Paolo Marchi
Resubmission - Version 3
11 Apr 2012 Submitted Manuscript version 3
5 Jul 2012 Reviewed Reviewer Report - Arnaud Scherpereel
21 Jul 2012 Reviewed Reviewer Report - Marc de Perrot
12 Oct 2012 Author responded Author comments - Paolo Marchi
Resubmission - Version 4
12 Oct 2012 Submitted Manuscript version 4
18 Nov 2012 Reviewed Reviewer Report - Marc de Perrot
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
4 Jan 2013 Editorially accepted
16 Jan 2013 Article published 10.1186/1471-2407-13-22

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Azienda Ospedaliera-Università di Padova, U.O. Chirurgia Toracica
(2)
Istituto Oncologico Veneto, U.O. Oncologia Medica 2
(3)
Istituto Europeo di Oncologia, Div. Chirurgia Toracica
(4)
Istituto Europeo di Oncologia, Div. Oncologia Medica
(5)
Istituto Nazionale Tumori “Regina Elena”, Div. Oncologia Medica
(6)
Ospedale dell’Angelo, Div. Oncologia Medica
(7)
Eli Lilly Italia
(8)
Eli Lilly UK, Erl Wood Manor, (former employee)
(9)
Istituto Nazionale Tumori “Regina Elena”, Div. Chirurgia Toracica

Advertisement